Several lines of evidence now suggest that cannabinoid compounds (CBD) are anti-convulsant and empirical evidence in many children is establishing conclusive evidence that cannabinoid therapy may be the most effective treatment available for epileptics. The way it works is that the basically negates the seizure from ever happening by modulating neuro-excitation (namely, keeping the neurons and synapses from getting overly excited which cause the seizure).
Patients report that they can wean themselves off prescription drugs, and still not experience seizures if they have a regular supply of CBD.
It has been shown that CBD (Cannabidiol) helps treat MS-like symptoms by preventing immune cells from mutating and attacking the insulating covers of nerve cells in the spinal cord. Mice having had an MS-like condition induced by partially paralyzing their limbs, we then given injections of cannabinoids. The mice responded by regaining movement, first twitching their tails and then beginning to walk normally again.
It was noted that the mice treated with CBD had much less inflammation in the spinal cord than their untreated counterparts. This shows that cannabis has a direct impact on the slowing and eventual reversal of MS. It is to be noted that after significant damage to the myelin sheath cannabis is no longer able to restore muscle function. Early detection is key to success.
Scientists at the University of Louisville School of Medicine in Kentucky have identified a previously unknown molecular target of cannabidiol (CBD), which may have significant therapeutic implications for Parkinson’s Disease (PD). Research on CBD has demonstrated that cannabis medicine like CBD Oil and other products may help to manage Parkinson’s Disease symptoms.
- The endocannabinoid system plays a major role in Parkinson’s Disease (PD).
- PD is associated with impairment of motor control after the loss of 60-80% of dopamine-producing neurons in a critical brain region.
- Cannabinoids have neuroprotectant, anti-oxidant and anti-inflammatory properties which can be beneficial for managing PD.
There were three clinical studies where doctors treated patients with CBD and measured whether and by how much those patients’ seizures were reduced. The largest of those studies included a total of 162 patients, treated with 99 percent CBD oil extract for 12 weeks; it found that CBD worked about as well as existing anti-epilepsy medications do in treatment-resistant sufferers. Study shows that CBD use reduced seizures by a monthly average of 36.5 percent; five patients saw their motor seizures completely disappear during the study period, and two patients became completely seizure-free.